86.49
price down icon0.39%   -0.34
pre-market  Vorhandelsmarkt:  88.50   2.01   +2.32%
loading

Finanzdaten der Vaxcyte Inc-Aktie (PCVX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
41.80%
114.47
196.68 113.03 87.15 71.19
Depreciation and Amortization
11.11%
1.00
0.90 0.80 0.80 0.70
Operating Income/Loss
41.80%
-114.47
-196.68 -113.03 -87.15 -71.19
Income/Loss From Continuing Operations Before Tax
47.44%
-95.02
-180.80 -92.66 -68.34 -60.46
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
47.44%
-95.02
-180.80 -92.66 -68.34 -60.46
Net Income/Loss
47.44%
-95.02
-180.80 -92.66 -68.34 -60.46
Preferred Stock Dividends And Other Adjustments
100.00%
-
442.93 -185.33 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
6,140%
111.69
1.7899 101.67 98.06 86.21
Diluted Average Shares
6,140%
111.69
1.7899 101.67 98.06 86.21
Basic Earnings Per Share
53.30%
-0.85
-1.82 -0.91 -0.70 -0.70
Diluted Earnings Per Share
53.30%
-0.85
-1.82 -0.91 -0.70 -0.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
100.00%
-
442.93 -185.33 - -
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):